Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Enovis Corp (ENOV)

Enovis Corp (ENOV)
32.50 -0.03 (-0.09%) 04/07/25 [NYSE]
13.00 x 200 52.00 x 200
Realtime by (Cboe BZX)
13.00 x 200 52.00 x 200
Realtime - - (-) -
Quote Overview for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
30.39
Day High
34.15
Open 31.20
Previous Close 32.53 32.53
Volume 1,260,500 1,260,500
Avg Vol 916,475 916,475
Stochastic %K 12.37% 12.37%
Weighted Alpha -46.58 -46.58
5-Day Change -5.71 (-14.94%) -5.71 (-14.94%)
52-Week Range 30.39 - 62.79 30.39 - 62.79
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,853,006
  • Shares Outstanding, K 56,963
  • Annual Sales, $ 2,108 M
  • Annual Income, $ -825,490 K
  • EBIT $ 35 M
  • EBITDA $ 970 M
  • 60-Month Beta 1.86
  • Price/Sales 0.91
  • Price/Cash Flow 1.76
  • Price/Book 0.75

Options Overview Details

View History
  • Implied Volatility 82.34% ( +2.99%)
  • Historical Volatility 48.54%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 82.34% on 04/07/25
  • IV Low 21.22% on 05/16/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 28
  • Volume Avg (30-Day) 387
  • Put/Call OI Ratio 4.24
  • Today's Open Interest 6,151
  • Open Int (30-Day) 6,875

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.74
  • Number of Estimates 4
  • High Estimate 0.76
  • Low Estimate 0.73
  • Prior Year 0.50
  • Growth Rate Est. (year over year) +48.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.39 +6.94%
on 04/07/25
Period Open: 37.72
40.69 -20.14%
on 03/25/25
-5.22 (-13.84%)
since 03/07/25
3-Month
30.39 +6.94%
on 04/07/25
Period Open: 44.76
49.38 -34.18%
on 01/27/25
-12.26 (-27.39%)
since 01/07/25
52-Week
30.39 +6.94%
on 04/07/25
Period Open: 60.64
62.79 -48.24%
on 04/09/24
-28.14 (-46.41%)
since 04/05/24

Most Recent Stories

More News
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment

Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment

INSP : 149.68 (+5.46%)
ENOV : 32.50 (-0.09%)
ITGR : 112.93 (-0.68%)
BLCO : 11.87 (-1.98%)
HAE : 58.95 (-3.17%)
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

ENOV : 32.50 (-0.09%)
2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down

2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down

ENOV : 32.50 (-0.09%)
ASTH : 29.29 (-2.59%)
ENSG : 124.63 (-3.63%)
Enovisâ„¢ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

ENOV : 32.50 (-0.09%)
3 Stocks Under $50 in the Doghouse

3 Stocks Under $50 in the Doghouse

ENOV : 32.50 (-0.09%)
WEN : 13.18 (-0.90%)
LXFR : 9.97 (-0.99%)
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

INSP : 149.68 (+5.46%)
ENOV : 32.50 (-0.09%)
GMED : 70.75 (+2.79%)
BLCO : 11.87 (-1.98%)
HAE : 58.95 (-3.17%)
Enovis to Participate in Upcoming Investor Conferences

ENOV : 32.50 (-0.09%)
Enovis Hits Another 52-Week Low. Here’s Why It’s a Contrarian Buy.

The orthopedic medical device company hit its 41st 52-week low. The stock looks unnecessarily beaten down, off 41% over the past 12 months and 62% from its all-time high in November 2021, making it a contrarian...

ENOV : 32.50 (-0.09%)
DHR : 180.62 (-0.63%)
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack

A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack

INSP : 149.68 (+5.46%)
ENOV : 32.50 (-0.09%)
ITGR : 112.93 (-0.68%)
STAA : 16.14 (+1.38%)
HAE : 58.95 (-3.17%)
Enovis (NYSE:ENOV) Exceeds Q4 Expectations

Enovis (NYSE:ENOV) Exceeds Q4 Expectations

ENOV : 32.50 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

See More

Key Turning Points

3rd Resistance Point 38.06
2nd Resistance Point 36.11
1st Resistance Point 34.30
Last Price 32.50
1st Support Level 30.54
2nd Support Level 28.59
3rd Support Level 26.78

See More

52-Week High 62.79
Fibonacci 61.8% 50.41
Fibonacci 50% 46.59
Fibonacci 38.2% 42.77
Last Price 32.50
52-Week Low 30.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades